PCV33 A LIFE-LONG COST-EFFECTIVENESS MARKOV MODEL COMPARING HIGH-DOSE VERSUS STANDARD DOSE STATIN THERAPY IN ACUTE CORONARY SYNDROME PATIENTS
Abstract
Authors
C Plesnila-Frank Y Asukai B Ehlken E Giannitsis J Rieber K Berger J Mardekian DA Rublee